FDA Considers “New Paradigm” To Facilitate Third Class Of Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
Approach that “under conditions of safe use” would allow nonprescription access to some categories of Rx drugs for treating chronic conditions is among topics for FDA hearing on switching Rx products to behind-the-counter status or other alternative routes.